In Law360, James C. Shehan discusses the lack of an appointed commissioner to lead the U.S. Food and Drug Administration He says: "At three months [into the Biden administration], … it's long enough that you're starting to have an impact.” Shehan adds: “What are the goals we're going to focus on in, say, 2021, the next 12 or the next 24 months — that's not being done."

Although the acting Commissioner and a former agency leader are being considered, Shehan thinks that “the longer it goes on … being open,” the more likely it is that someone else entirely will be named.